GLP1 Technology
GLP-1 Technology offers scalable, cost-efficient production of GLP-1 and peptide therapeutics. It is a B2B biotech manufacturing platform built on AI-engineered biocatalysts that catalyze enzymatic reactions in water, avoiding toxic solvents. The platform targets pharmaceutical manufacturing with gains like 4x batch output and 60–80% cost reductions. Designed to integrate into existing workflows, it aims to make next-generation peptide therapeutics more accessible and sustainable at scale.
GLP1 Technology
GLP-1 Technology offers scalable, cost-efficient production of GLP-1 and peptide therapeutics. It is a B2B biotech manufacturing platform built on AI-engineered biocatalysts that catalyze enzymatic reactions in water, avoiding toxic solvents. The platform targets pharmaceutical manufacturing with gains like 4x batch output and 60–80% cost reductions. Designed to integrate into existing workflows, it aims to make next-generation peptide therapeutics more accessible and sustainable at scale.